Clinical Trial Update: A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating the PET imaging tracer [18F]AH-111585 for detecting tumors and angiogenesis, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• High-grade Glioma
• Lung Cancer
• Melanoma
• Sarcoma

Drugs mentioned

• [18F]AH-111585

Snippet

Sponsor: GE Healthcare | Conditions: High-grade Glioma, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-08-08